Research comparison
A side-by-side comparison of Ipamorelin and CJC 1295 (without DAC) as they are characterised in the peer-reviewed research literature. Pulsatile GH secretagogue research. Both compounds are supplied for in-vitro laboratory research only.
| Ipamorelin | CJC 1295 (without DAC) | |
|---|---|---|
| Research area | GHRH / Secretagogue Research | GHRH / Secretagogue Research |
| Sizes stocked | 2mg, 5mg, 10mg | 2mg, 5mg, 10mg |
| Reference | Full Ipamorelin page → | Full CJC 1295 (without DAC) page → |
Ipamorelin is a synthetic pentapeptide characterised in the literature as a selective agonist at the ghrelin / growth-hormone-secretagogue receptor. Supplied as lyophilised powder for in-vitro research use only.
CJC 1295 without DAC, also known in the literature as Mod GRF 1-29, is a synthetic GHRH analogue comprising the first 29 amino acids of GHRH with four amino-acid substitutions for stability. Supplied as lyophilised powder for in-vitro research use only.
Both compounds are characterised in the research literature within pulsatile gh secretagogue research. Researchers typically consult the primary peer-reviewed publications for each compound before selecting one for a specific experimental protocol. The two are frequently studied in parallel and occasionally cited together in comparative pharmacology reviews.
Both Ipamorelin and CJC 1295 (without DAC) are supplied as lyophilised powder and reconstituted with bacteriostatic water using standard laboratory technique. For full reconstitution methodology see our Research Handling Guide, or compute resulting mg/ml concentrations with the Reconstitution Volume Calculator.
Every batch of both compounds is independently HPLC-verified by Janoshik Analytical at 99%+ purity. The lab report is supplied with every order and carries a unique verification key.